Financhill
Back

Rocket Pharmaceuticals Stock Predictions

Rocket Pharmaceuticals Stock Forecast

  • Is Rocket Pharmaceuticals Stock Undervalued?
    The current Rocket Pharmaceuticals [RCKT] share price is $2.51. The Score for RCKT is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • RCKT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Rocket Pharmaceuticals Stock Go Up Next Year?

Data Unavailable

Rocket Pharmaceuticals Stock Rating

Data Unavailable

Rocket Pharmaceuticals Stock Price History

Is RCKT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RCKT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
rocketpharma.com

52-Week Data

52-Week High:
26.98
52-Week Low:
2.19

Prediction Charts

Market Cap:
270.4M
Price in USD:
2.51
Volume:
7.4M
Beta:
1.57

Technical Analysis

SMA50:
6.42
SMA100:
8.32
SMA200:
12.42
52-Wk Change:
-88.3%

Stock Predictions

  • Is Rocket Pharmaceuticals stock public?
    Yes, Rocket Pharmaceuticals is a publicly traded company.
  • What is the Rocket Pharmaceuticals stock quote today?
    The Rocket Pharmaceuticals stock price is 2.51 USD today.
  • How to buy Rocket Pharmaceuticals stock online?
    You can buy Rocket Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-12 7.25 7.00 7.39 6.96
May-13 7.00 6.62 7.13 6.23
May-14 6.53 6.06 6.95 5.90
May-15 6.01 6.73 7.14 5.72
May-16 6.87 6.50 6.87 6.36
May-19 6.35 6.45 6.74 6.29
May-20 6.50 6.85 6.89 6.38
May-21 6.68 6.59 6.83 6.43
May-22 6.51 6.56 6.80 6.51
May-23 6.35 6.27 6.43 6.11
May-27 2.30 2.33 2.79 2.19
May-28 2.38 2.48 2.64 2.35
May-29 2.50 2.62 2.67 2.40
May-30 2.58 2.51 2.61 2.40

Rocket Pharmaceuticals Earnings

Data Unavailable

Rocket Pharmaceuticals Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.17 per share, an increase this year of $0.67 per share, and an increase next year of $0.68 per share.

* Rocket Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.